4.38
4.38 (0%)
As of Feb 14, 2025
Neurometrix, Inc. [NURO]
Source:
Company Overview
NeuroMetrix is a commercial stage neurotechnology company based in Woburn, MA whose mission is to improve individual and population health through innovative medical devices and technology solutions for pain syndromes and neurological disorders. The Company has created the market for point-of-care nerve testing and introduced sophisticated wearable technology for chronic pain syndrome.
| Country | United States |
| Headquarters | waltham, massachusetts |
| Phone Number | (781) 890-9989 |
| Industry | manufacturing |
| CEO | Shai N. Gozani, M.D., Ph.D. |
| Website | www.neurometrix.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $3 |
| Operating Profit | $-8.8 |
| Net Income | $-7.8 |
| Net Cash | $-0.3 |
Profit Ratios
| Gross Margin | $1.7 |
| Operating Margin | -289.6 |
| Profit as % of Revenues | -21.5% |
| Profit as % of Assets | -42.5% |
| Profit as % of Stockholder Equity | -54.5% |
Management Effectiveness
| Return on Equity | -54.5% |
| Return on Assets | -50.9% |
| Turnover Ratio | 16.5% |
| EBITA | $-8.8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $15.3 |
| Total Liabilities | $1 |
| Operating Cash Flow | $-7.1 |
| Investing Cash Flow | $5.3 |
| Financing Cash Flow | $1.5 |
